Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
批准号:
10611940
负责人:
Maxim Frolov
金额:
$57.02万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-04-30
关键词:
AddressAdultAffectAnimalsApoptosisAtlasesCell Differentiation processCell ProliferationCellsComplementDevelopmentDrosophila genusE2F transcription factorsEventEyeFamilyFat BodyGene ExpressionGeneticGenomicsGrowthHumanInvestigationKnowledgeLinkMalignant NeoplasmsMetabolismMuscle DevelopmentMutationMyofibrillogenesisPathway interactionsPhotoreceptorsPopulationProtein FamilyProteinsResearchRetinoblastomaRetinoblastoma ProteinSkeletal MuscleSystemTechnologyTissuesTumor Suppressor Proteinscell typedroplet sequencingflygenetic analysisimaginal discin vivoinnovationmembermodel organismmutantprogramsretinoblastoma pathwayretinoblastoma tumor suppressorsingle-cell RNA sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Inactivation of the retinoblastoma (Rb) tumor suppressor pathway is an early obligatory event in human
cancer. One of the key targets of the Rb pathway is the family of E2F transcription factors, which regulate
cell proliferation and apoptosis. Overlapping and redundant functions of mammalian members of the E2F
and Rb tumor suppressor protein (pRB) families is a major hurdle in identification of their in vivo function.
Model organisms such as Drosophila provide attractive alternatives to complement studies in mammalian
systems due to high conservation of the Rb pathway and the amenability of flies to genetic analysis. Our
research program is aimed at addressing two fundamental questions: what are the essential functions of
the Rb pathway in development, and how do Rb pathway mutations affect different cell types in the
tissue? To address these questions, we are using genetic, genomic and single-cell RNA-Seq approaches.
We have identified adult skeletal muscle where E2F and Rb proteins regulate growth and
myofibrillogenesis, to be important for viability. We will determine how the Rb pathway regulates gene
expression and cellular metabolism during muscle development, and will investigate the systemic effects
inferred by E2F deficiency in specific tissues such as adult skeletal muscle and the fat body. We have
adapted Drop-Seq, a single-cell RNA-sequencing technology, to determine the effect of Rb pathway
mutations in heterogeneous tissue. We have established the feasibility of this approach by building the
first cell atlas of the Drosophila wild-type eye imaginal disc. Profiling of Rb mutants by Drop-Seq revealed
elevated intracellular acidification in a small cell population that makes them uniquely sensitive to
apoptosis. The link between apoptosis and acidification will be evaluated further. Among other questions
to be addressed with Drop-seq is the investigation of why inactivation of the Hippo pathway induces
dedifferentiation of Rb mutant photoreceptors. Collectively, the proposed research will enhance our
knowledge of pRB and its functions during animal development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10396992
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:10794727
-
项目类别:
-
资助金额:$3.4万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
-
批准号:9908112
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2019
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8991496
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
-
批准号:8816779
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2015
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8319369
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8708116
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Rb and Hippo tumor suppressor pathways in differentiation
-
批准号:9355642
-
项目类别:
-
资助金额:$33.58万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8019364
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Genetic integration of pRB and Hippo tumor suppressor pathways
-
批准号:8514010
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2011
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:8054279
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7195896
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7351791
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7589721
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
Characterization of novel modifiers of dE2F/RBF function
-
批准号:7778250
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2007
-
负责人:Maxim Frolov
-
依托单位:
海外基金